SR 2555

Known as: 1H-imidazole-1-acetamide, N,N-bis(2-hydroxyethyl)-2-nitro-, SR-2555 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-1994
01219801994

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
-The effect of combinations of the conventional chemotherapeutic agent 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU) and… (More)
  • figure 2
  • table I
  • figure 3
  • figure 4
  • table II
Is this relevant?
1986
1986
Two new radiosensitizing drugs, SR-2508 and SR-2555, were studied for their in vivo toxicity and absorption properties. For both… (More)
Is this relevant?
1984
1984
Systems developed to assay oncogenic transformation in vitro represent a rapid and powerful tool to screen and compare… (More)
Is this relevant?
1982
1982
The hypoxic cytotoxicity of four different 2-nitroimidazoles of similar electron affinities but different lipophilicities was… (More)
Is this relevant?
1982
1982
The effect of combinations of the conventional chemotherapeutic agent 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and… (More)
  • figure 2
  • table I
  • figure 3
  • figure 4
  • table II
Is this relevant?
1981
1981
We have compared the mouse pharmacokinetics of six analogues of the hypoxic cell sensitizer misonidazole (MISO). The analogues… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
1980
Review
1980
The comparative pharmacokinetics of various nitroimidazole radiosensitizers in different species are reviewed. Radiosensitization… (More)
Is this relevant?